Nutex Health Inc./$NUTX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Nutex Health Inc.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
- Ticker
- $NUTX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 1,037
- Headquarters
- Houston, United States
- Website
- www.nutexhealth.com
NUTX Metrics
BasicAdvanced
$1.4B
8.33
$25.24
1.99
-
Price and volume
Market cap
$1.4B
Beta
1.99
52-week high
$226.16
52-week low
$83.99
Average daily volume
147K
Financial strength
Current ratio
4.996
Quick ratio
4.794
Long term debt to equity
0.649
Total debt to equity
0.685
Interest coverage (TTM)
24.33%
Profitability
EBITDA (TTM)
502.267
Gross margin (TTM)
54.51%
Net profit margin (TTM)
21.25%
Operating margin (TTM)
56.84%
Effective tax rate (TTM)
20.67%
Revenue per employee (TTM)
$820,000
Management effectiveness
Return on assets (TTM)
33.32%
Return on equity (TTM)
64.56%
Valuation
Price to earnings (TTM)
8.326
Price to revenue (TTM)
1.694
Price to book
3.65
Price to tangible book (TTM)
4
Price to free cash flow (TTM)
5.278
Free cash flow yield (TTM)
18.95%
Free cash flow per share (TTM)
39.808
Growth
Revenue change (TTM)
6.88%
Earnings per share change (TTM)
172.78%
3-year revenue growth (CAGR)
62.49%
3-year earnings per share growth (CAGR)
-36.89%
What the Analysts think about NUTX
Analyst ratings (Buy, Hold, Sell) for Nutex Health Inc. stock.
Analyst projections of the future price of Nutex Health Inc. stock.
Bulls say / Bears say
Hospital visits rose 9.6% year on year in Q2, with same-hospital visits up 6.3%; Population Health Management revenue also grew 15.8%. Rising use points to underlying demand even as reported revenue fell. (Nutex Health)
Operating cash flow reached $109.7 million in the first half, and cash stood at $205.2 million against $31.1 million of long-term debt. This gives Nutex financial room to support growth and manage volatility. (Nutex Health)
Nutex opened its 28th hospital in West Little Rock in August, extending its footprint to 12 states. New facilities give the company capacity to attract more patients as they ramp up. (Nutex Health)
Q2 revenue fell 13.6% year on year and same-hospital revenue fell 12.1%; first-half revenue was down 6.3%. Stronger patient volumes have not yet translated into revenue growth, although Nutex says the comparison was affected by favourable IDR results in the prior-year period. (Nutex Health)
First-half net income attributable to Nutex included a $25 million benefit from revised arbitration-fee estimates, after contract-services expense was reduced by $52.3 million. The resulting profit surge is not a clean guide to recurring earnings. (SEC)
Nutex generally operates out of network and uses the federal IDR process to resolve payment disputes. After a court ruling on QPA calculations, the company said the timing and content of new rules remain unknown, leaving reimbursement economics exposed to regulatory change. (SEC, Nutex Health)
Data summarised monthly by Lightyear AI. Last updated on 16 Oct 2026.
NUTX Financial Performance
Revenues and expenses
NUTX Earnings Performance
Company profitability
Upcoming events
No upcoming events
NUTX News
AllArticlesVideos
Funds containing NUTX
Fund name | Fund size | $NUTX weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.04% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.04% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.03% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.03% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.